HR 4106 · 116th Congress 2019–2021, ended

Responsibility in Drug Advertising Act of 2019

Introduced Jul 30, 2019 Originated House Sponsor Rosa L. DeLauro D-CT

Fact sheet

Latest action · Jul 31, 2019 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJul 30, 2019
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Responsibility in Drug Advertising Act of 2019

This bill prohibits direct-to-consumer advertising of a drug in the first three years after the drug's approval. The Food and Drug Administration may (1) waive the third year of this prohibition for a drug if direct-to-consumer advertising of the drug would have an affirmative value to public health, or (2) extend the prohibition if the drug has significant adverse health effects.

Cosponsors 3

Members who signed on, in the order they did. Signatures ran from Jul 30, 2019 to Aug 2, 2019, with 2 there on the day it was introduced.

SeatCosponsorSigned on
D-AZRaúl M. GrijalvaOriginalJul 30, 2019
D-CARo KhannaOriginalJul 30, 2019
D-NHChris PappasAug 2, 2019

Actions 3

Everything that happened, newest first.

  1. Jul 31, 2019Referred to the Subcommittee on Health.
  2. Jul 30, 2019Introduced in House
  3. Jul 30, 2019Referred to the House Committee on Energy and Commerce.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 2452Medicare for America Act of 2019Related billMay 31, 2019
S 3180Responsibility in Drug Advertising Act of 2020Identical billJan 9, 2020

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jul 30, 2019Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

$1 $5 $10

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.